Dr. Jui Chaugule, PhD, is the Principal Investigator and Head of Research at ProViZiGen, where she leads the development of HydroGEN™, a novel biologic for preventing post-traumatic osteoarthritis. She earned her PhD in Biochemistry from The Graduate Center, CUNY, and has over 10 years of experience in biomaterials, protein engineering, tissue engineering, and therapeutic development. Her expertise includes protein design, purification, characterization, and translational research. An award-winning educator and researcher, Dr. Chaugule has secured NIH and NSF funding and is dedicated to advancing innovative biologics from the laboratory to clinical application to improve patient outcomes.